Parabilis Medicines raises $305 million as CEO warms to an IPO Company is the latest biotech firm to attract crossover investors

https://www.statnews.com/2026/01/08/parabilis-medicines-biotech-investors-crossover/ By Allison DeAngelisJan. 8, 2026 Biotech Startups and Venture Capital Reporter